{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:40:42Z","timestamp":1794346842884,"version":"4.9.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008673","name":"Center for AIDS Research, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 AI124843"],"award-info":[{"award-number":["R01 AI124843"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","award":["US 10544188 B2"],"award-info":[{"award-number":["US 10544188 B2"]}],"id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA030199"],"award-info":[{"award-number":["P30 CA030199"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA195227"],"award-info":[{"award-number":["R01 CA195227"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.xcrm.2020.100037","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T10:38:28Z","timestamp":1592908708000},"page":"100037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacological Activation of Non-canonical NF-\u03baB Signaling Activates Latent HIV-1 Reservoirs In\u00a0Vivo"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-1042","authenticated-orcid":false,"given":"Lars","family":"Pache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Teriete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-4917","authenticated-orcid":false,"given":"Mohamed S.A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Dimapasoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-391X","authenticated-orcid":false,"given":"Camille","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Celeridad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-7893","authenticated-orcid":false,"given":"Adam M.","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-2982","authenticated-orcid":false,"given":"Vicente","family":"Planelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.P.","family":"Cosford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome A.","family":"Zack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit K.","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2020.100037_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11904-009-0033-9","article-title":"Mechanisms of HIV latency: an emerging picture of complexity","volume":"7","author":"Margolis","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.xcrm.2020.100037_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2014.05.026","article-title":"Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1","volume":"134","author":"Siliciano","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2020.100037_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-med-052716-031710","article-title":"Novel latency reversal agents for HIV-1 cure","volume":"69","author":"Spivak","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2020.100037_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100037_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/jiu155","article-title":"HIV-1 expression within resting CD4+ T\u00a0cells after multiple doses of vorinostat","volume":"210","author":"Archin","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100037_bib6","doi-asserted-by":"crossref","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2020.100037_bib7","doi-asserted-by":"crossref","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in\u00a0vivo","volume":"11","author":"S\u00f8gaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2020.100037_bib8","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2020.100037_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex\u00a0vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in\u00a0vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2020.100037_bib10","doi-asserted-by":"crossref","first-page":"e1006575","DOI":"10.1371\/journal.ppat.1006575","article-title":"In\u00a0vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell \u201ckick\u201d and \u201ckill\u201d in strategy for virus eradication","volume":"13","author":"Marsden","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2020.100037_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10637-010-9557-5","article-title":"Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study","volume":"30","author":"Morgan","year":"2012","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xcrm.2020.100037_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100037_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100037_bib14","doi-asserted-by":"crossref","first-page":"eaao4521","DOI":"10.1126\/scitranslmed.aao4521","article-title":"TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy","volume":"10","author":"Lim","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2020.100037_bib15","doi-asserted-by":"crossref","first-page":"e01163-19","DOI":"10.1128\/AAC.01163-19","article-title":"PD-1 blockade and TLR7 activation lack therapeutic benefit in chronic simian immunodeficiency virus-infected macaques on antiretroviral therapy","volume":"63","author":"Bekerman","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2020.100037_bib16","doi-asserted-by":"crossref","first-page":"a008730","DOI":"10.1101\/cshperspect.a008730","article-title":"Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation","volume":"5","author":"Silke","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.xcrm.2020.100037_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.12688\/f1000research.10625.1","article-title":"Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins","volume":"6","author":"Finlay","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2020.100037_bib18","first-page":"211","article-title":"Chapter 13 - The discovery and development of Smac mimetics-small-molecule antagonists of the inhibitor of apoptosis proteins","volume":"46","author":"Condon","year":"2011","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1535-7163.MCT-13-0153","article-title":"Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs","volume":"13","author":"Finlay","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2020.100037_bib20","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.bmcl.2011.05.049","article-title":"Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP","volume":"21","author":"Gonz\u00e1lez-L\u00f3pez","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.xcrm.2020.100037_bib21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1098231","article-title":"A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death","volume":"305","author":"Li","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100037_bib22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/cb3005512","article-title":"Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP","volume":"8","author":"Vamos","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xcrm.2020.100037_bib23","doi-asserted-by":"crossref","first-page":"e0161952","DOI":"10.1371\/journal.pone.0161952","article-title":"Characterization of potent SMAC mimetics that sensitize cancer cells to TNF family-induced apoptosis","volume":"11","author":"Welsh","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2020.100037_bib24","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1038\/sj.emboj.7600391","article-title":"Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers","volume":"23","author":"Bonizzi","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2020.100037_bib25","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0711122105","article-title":"Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation","volume":"105","author":"Mahoney","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2020.100037_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2020.100037_bib27","doi-asserted-by":"crossref","first-page":"e88347","DOI":"10.1371\/journal.pone.0088347","article-title":"NF-\u03baB inducing kinase, a central signaling component of the non-canonical pathway of NF-\u03baB, contributes to ovarian cancer progression","volume":"9","author":"Uno","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2020.100037_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chom.2015.08.009","article-title":"BIRC2\/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac mimetics to promote reversal of viral latency","volume":"18","author":"Pache","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2020.100037_bib29","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1021\/jm500176w","article-title":"Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies","volume":"57","author":"Condon","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib30","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/jm040037k","article-title":"Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer","volume":"47","author":"Oost","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib31","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/jm101505d","article-title":"A potent and orally active antagonist (SM-406\/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment","volume":"54","author":"Cai","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib32","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1021\/jm300060k","article-title":"Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)","volume":"55","author":"Flygare","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib33","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-15-0365","article-title":"Promises and challenges of Smac mimetics as cancer therapeutics","volume":"21","author":"Fulda","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2020.100037_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/bs.ircmb.2016.09.004","article-title":"Smac mimetics to therapeutically target IAP proteins in cancer","volume":"330","author":"Fulda","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.xcrm.2020.100037_bib35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/1535-7163.MCT-17-0848","article-title":"ASTX660, a novel non-peptidomimetic antagonist of cIAP1\/2 and XIAP, potently induces TNF\u03b1-dependent apoptosis in cancer cell lines and inhibits tumor growth","volume":"17","author":"Ward","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2020.100037_bib36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2010.212","article-title":"Smac mimetics: implications for enhancement of targeted therapies in leukemia","volume":"24","author":"Weisberg","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2020.100037_bib37","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/JTO.0b013e318226b4a6","article-title":"BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in\u00a0vitro","volume":"6","author":"Li","year":"2011","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2020.100037_bib38","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1158\/0008-5472.CAN-08-2655","article-title":"SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1\/2 and XIAP","volume":"68","author":"Lu","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2020.100037_bib39","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1158\/1535-7163.MCT-13-0017","article-title":"Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma","volume":"12","author":"Wu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2020.100037_bib40","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-15-0475","article-title":"A phase I study of the SMAC-mimetic birinapant in adults with refractory solid tumors or lymphoma","volume":"14","author":"Amaravadi","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2020.100037_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clml.2015.02.020","article-title":"Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study","volume":"15","author":"DiPersio","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.xcrm.2020.100037_bib42","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2013.52.3993","article-title":"Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors","volume":"32","author":"Infante","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2020.100037_bib43","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1128\/JVI.01383-08","article-title":"Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency","volume":"82","author":"Pearson","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jmb.2009.04.033","article-title":"Structural basis for bivalent Smac-mimetics recognition in the IAP protein family","volume":"392","author":"Cossu","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.xcrm.2020.100037_bib45","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex\u00a0vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100037_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.xcrm.2020.100037_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-virology-101416-041703","article-title":"Humanized mouse models for human immunodeficiency virus infection","volume":"4","author":"Marsden","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib48","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1128\/AAC.01077-15","article-title":"Ex\u00a0vivo bioactivity and HIV-1 latency reversal by ingenol dibenzoate and panobinostat in resting CD4(+) T\u00a0cells from aviremic patients","volume":"59","author":"Spivak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2020.100037_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jim.2014.04.008","article-title":"Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL\/6 Rag2(-\/-)\u03b3c(-\/-)CD47(-\/-) background","volume":"407","author":"Lavender","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2020.100037_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/JVI.06366-11","article-title":"HIV latency in the humanized BLT mouse","volume":"86","author":"Marsden","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"Melkus","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2020.100037_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2005.10.016","article-title":"A novel small reporter gene and HIV-1 fitness assay","volume":"133","author":"Ali","year":"2006","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.xcrm.2020.100037_bib53","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1128\/JVI.72.8.6520-6526.1998","article-title":"In\u00a0vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus","volume":"72","author":"Jamieson","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib55","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/jm0499108","article-title":"Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein\/caspase-9 interaction site","volume":"47","author":"Sun","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib56","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/jm101651b","article-title":"Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity","volume":"54","author":"Sun","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib57","doi-asserted-by":"crossref","first-page":"ofw189","DOI":"10.1093\/ofid\/ofw189","article-title":"Ongoing clinical trials of human immunodeficiency virus latency-reversing and immunomodulatory agents","volume":"3","author":"Delagr\u00e8verie","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100037_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molmed.2015.11.004","article-title":"HIV-1 eradication: early trials (and tribulations)","volume":"22","author":"Spivak","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2020.100037_bib59","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","article-title":"Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy","volume":"30","author":"Guti\u00e9rrez","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2020.100037_bib60","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1128\/JVI.00161-10","article-title":"Combinatorial latency reactivation for HIV-1 subtypes and variants","volume":"84","author":"Burnett","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib61","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in\u00a0vitro and ex\u00a0vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2020.100037_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","article-title":"Targeting HIV latency: pharmacologic strategies toward eradication","volume":"18","author":"Xing","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.xcrm.2020.100037_bib63","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/v5061571","article-title":"Bromodomain proteins in HIV infection","volume":"5","author":"Boehm","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2020.100037_bib64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2020.100037_bib65","doi-asserted-by":"crossref","first-page":"e00233-19","DOI":"10.1128\/JVI.00233-19","article-title":"Specific activation in\u00a0vivo of HIV-1 by a bromodomain inhibitor from monocytic cells in humanized mice under antiretroviral therapy","volume":"93","author":"Li","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100037_bib66","doi-asserted-by":"crossref","first-page":"FSO372","DOI":"10.4155\/fsoa-2018-0115","article-title":"Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy","volume":"5","author":"Alqahtani","year":"2019","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.xcrm.2020.100037_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-016-0268-7","article-title":"In\u00a0vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection","volume":"13","author":"Tsai","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2020.100037_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2020.100037_bib69","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1021\/jm401075x","article-title":"Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582)","volume":"56","author":"Hennessy","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2020.100037_bib70","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","article-title":"Systemic HIV and SIV latency reversal via non-canonical NF-\u03baB signalling in\u00a0vivo","volume":"578","author":"Nixon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100037_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12977-020-00516-2","article-title":"Benefits and limitations of humanized mice in HIV persistence studies","volume":"17","author":"Marsden","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2020.100037_bib72","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.xcrm.2020.100037_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/meth.1997.0488","article-title":"Preparation and maintenance of SCID-hu mice for HIV research","volume":"12","author":"Bristol","year":"1997","journal-title":"Methods"},{"key":"10.1016\/j.xcrm.2020.100037_bib74","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.2971269","article-title":"The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function","volume":"241","author":"McCune","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100037_bib75","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1038\/mtna.2015.3","article-title":"RNAi-mediated CCR5 knockdown provides HIV-1 resistance to memory T\u00a0cells in humanized BLT mice","volume":"4","author":"Shimizu","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2020.100037_bib76","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1002\/psp4.9","article-title":"A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve","volume":"4","author":"Goswami","year":"2015","journal-title":"CPT Pharmacometrics Syst. Pharmacol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120300495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120300495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:43:11Z","timestamp":1762987391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379120300495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2666379120300495"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100037","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Activation of Non-canonical NF-\u03baB Signaling Activates Latent HIV-1 Reservoirs In\u00a0Vivo","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100037"}}